Clinical trial

Randomized Trial of Two Antimalarial Treatments for Clearing Low Density…

NCT00330902 · London School of Hygiene and Tropical Medicine, Other · Completed

Key facts

NCT number NCT00330902
Title Randomized Trial of Two Antimalarial Treatments for Clearing Low Density P.Falciparum Parasitaemia in Sudan
Official title Randomized Trial of Sulfadoxine-Pyrimethamine Plus Artesunate (SP+AS) Versus SP+AS Plus Primaquine for Clearance of Low Density P. Falciparum Infection in Eastern Sudan
Lead sponsor London School of Hygiene and Tropical Medicine, Other
Collaborators Tropical Medicine Research Institute World Health Organization
Status Completed
Phase Phase 3
Study type Interventional
Conditions Plasmodium Infections
Intervention type Drug
Interventions sulfadoxine-pyrimethamine (SP) plus artesunate (AS), primaquine (PQ) plus SP+AS
Enrollment 104
Start date Jan 1, 2004
Completion Nov 1, 2004
First posted May 29, 2006
Last update posted Oct 31, 2007
Countries Sudan

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies